Nephrocare Health Services Ltd Gains 1.03%: 6 Key Factors Driving the Week’s Mixed Momentum
2026-11-21 09:02:46Key Events This Week 16 Nov: Upgrade to Sell rating on technical improvements 17 Nov: Mildly bearish momentum amid mixed technical signals 18 Nov: Strong quarterly gains reported with positive financial trend 19 Nov: Technical momentum shifts to mildly bearish 20 Nov: Stock closes at Rs.658.30, up 2.55% on the day Week OpenRs.651.60 ...
Read More
Nephrocare Health Services Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-11-19 08:06:28Nephrocare Health Services Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. Despite a strong year-to-date return of 38.99%, recent technical indicators suggest caution as the stock’s price momentum shows signs of weakening amid mixed signals from key oscillators and moving averages.
Read More
Nephrocare Health Services Ltd Reports Strong Quarterly Gains Amid Positive Financial Trend
2026-11-18 16:00:08Nephrocare Health Services Ltd has demonstrated a positive shift in its financial trend for the quarter ended September 2026, marked by record-high revenues and profitability metrics despite rising interest expenses. The company’s recent quarterly performance signals a stabilising growth trajectory, although margin pressures remain a concern for investors.
Read More
Nephrocare Health Services Ltd Faces Mildly Bearish Momentum Amid Mixed Technical Signals
2026-11-17 08:03:47Nephrocare Health Services Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid mixed signals from key momentum and volume metrics.
Read More
Nephrocare Health Services Ltd Shows Mixed Technical Signals Amid Price Momentum Shift
2026-11-16 08:04:55Nephrocare Health Services Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways consolidation phase. Despite a strong one-week return of 8.44%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators.
Read MoreNephrocare Health Services Declines 2.44% Amid Valuation and Technical Shifts
2026-11-07 09:02:06Key Events This Week 2 Nov: Valuation reassessment amid price correction 3 Nov: Positive momentum shift with mixed technical signals 5 Nov: Strong quarterly gains reported amid margin pressures 5 Nov: Downgrade to Sell due to quality and valuation concerns 6 Nov: Technical momentum shifts to mildly bearish 6 Nov: Week closes at ₹600.90 (-2.44%) <div class="stat-label"...
Read More
Nephrocare Health Services Ltd Reports Strong Quarterly Gains Amid Margin Pressures
2026-11-05 11:01:13Nephrocare Health Services Ltd has delivered a robust quarterly performance for September 2026, registering record-high revenues and profitability metrics despite rising interest expenses. The company’s financial trend has shifted from very positive to positive, reflecting both operational strength and emerging cost challenges in the healthcare services sector.
Read More
Nephrocare Health Services Ltd Downgraded to Sell Amid Valuation and Quality Concerns
2026-11-05 08:49:44Nephrocare Health Services Ltd has seen its investment rating downgraded from Hold to Sell as of 4 Nov 2026, reflecting deteriorations in quality metrics and valuation concerns despite some technical improvements. The healthcare services company, classified as a small-cap with a current market price of ₹620.75, faces challenges on multiple fronts including below-average quality grades, very expensive valuation multiples, and mixed financial trends. This comprehensive analysis explores the four key parameters that triggered the rating change and what it means for investors.
Read More
Nephrocare Health Services Ltd Downgraded to Sell Amid Quality Parameter Decline
2026-11-05 08:00:52Nephrocare Health Services Ltd has seen its quality grade downgraded from Hold to Sell following a reassessment of its business fundamentals. Despite a robust year-to-date stock return of 32.3%, the company’s underlying financial quality indicators have weakened, raising concerns about its operational consistency and capital efficiency compared to peers in the healthcare services sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20-Nov-2026 | Source : BSEPursuant to Reg 30 of the SEBI Listing Regulations we hereby inform that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.
17-Nov-2026 | Source : BSEWe hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
17-Nov-2026 | Source : BSEPursuant to Reg 30 of SEBI Listing Regulations 2015 we hereby inform that the Company has approved allotment of 342130 equity shares of Rs. 2/- each pursuant to the exercise of stock options under NephroPlus ESOP Scheme 2011.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available